Credit Suisse Prescribes Underperform Rating For Dr. Reddy's With Drop In U.S. Sales

By: via Benzinga
Credit Suisse downgraded Dr.Reddy's Laboratories Ltd (ADR) (NYSE: RDY) to Underperform from Neutral and cut its EPS outlook ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.